Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Isatuximab in Combination With Novel Agents in RRMM - Master Protocol

Sanofi · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
plasma cell myeloma refractory, anti-cd38 monoclonal antibody, master protocol, combination therapy, cd38 resistance, interleukin 2, rock2 inhibitor, anti-cd47 agent, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 911872
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.